 | • レポートコード：MRC2-11QY04625 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は部位特異的ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他）市場規模、用途別（真菌感染症治療、がん・腫瘍治療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別部位特異的ドラッグデリバリーの競争状況、市場シェア ・世界の部位特異的ドラッグデリバリー市場：種類別市場規模 2015年-2020年（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他） ・世界の部位特異的ドラッグデリバリー市場：種類別市場規模予測 2021年-2026年（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他） ・世界の部位特異的ドラッグデリバリー市場：用途別市場規模 2015年-2020年（真菌感染症治療、がん・腫瘍治療、その他） ・世界の部位特異的ドラッグデリバリー市場：用途別市場規模予測 2021年-2026年（真菌感染症治療、がん・腫瘍治療、その他） ・北米の部位特異的ドラッグデリバリー市場分析：米国、カナダ ・ヨーロッパの部位特異的ドラッグデリバリー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの部位特異的ドラッグデリバリー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の部位特異的ドラッグデリバリー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの部位特異的ドラッグデリバリー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action or is prematurely metabolized or excreted. In other instances, the drug travels rather freely throughout the body and not only acts on the desired target tissues but also causes undesirable effects on nontarget tissues. This lack of target specificity is attributable, for the most part, to the formidable barriers that the body presents to the successful delivery of a drug from its site of administration to its site of action: a drug normally encounters or must by pass various molecules, enzymes, cells, membranes, and organs before reaching its designated target.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Site-Specific Drug Delivery in US$ by following Product Segments.: Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel and other.
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market Analysis and Insights: Global Site-Specific Drug Delivery Market
The global Site-Specific Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Site-Specific Drug Delivery Scope and Market Size
Site-Specific Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Site-Specific Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market segment by Type, the product can be split into
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other
Market segment by Application, split into
Fungal Infection Therapy
Cancer & Tumor Therapy
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Site-Specific Drug Delivery Revenue
1.4 Market by Type
1.4.1 Global Site-Specific Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liposomal Doxorubicin
1.4.3 Liposomal Amphoteracin B
1.4.4 Liposomal Paclitaxel
1.4.5 Other
1.5 Market by Application
1.5.1 Global Site-Specific Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Fungal Infection Therapy
1.5.3 Cancer & Tumor Therapy
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Site-Specific Drug Delivery Market Perspective (2015-2026)
2.2 Global Site-Specific Drug Delivery Growth Trends by Regions
2.2.1 Site-Specific Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Site-Specific Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Site-Specific Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Site-Specific Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Site-Specific Drug Delivery Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Site-Specific Drug Delivery Players by Market Size
3.1.1 Global Top Site-Specific Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Site-Specific Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Site-Specific Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Site-Specific Drug Delivery Market Concentration Ratio
3.2.1 Global Site-Specific Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Site-Specific Drug Delivery Revenue in 2019
3.3 Site-Specific Drug Delivery Key Players Head office and Area Served
3.4 Key Players Site-Specific Drug Delivery Product Solution and Service
3.5 Date of Enter into Site-Specific Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Site-Specific Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Site-Specific Drug Delivery Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Site-Specific Drug Delivery Market Size by Application (2015-2020)
5.2 Global Site-Specific Drug Delivery Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Site-Specific Drug Delivery Market Size (2015-2020)
6.2 Site-Specific Drug Delivery Key Players in North America (2019-2020)
6.3 North America Site-Specific Drug Delivery Market Size by Type (2015-2020)
6.4 North America Site-Specific Drug Delivery Market Size by Application (2015-2020)
7 Europe
7.1 Europe Site-Specific Drug Delivery Market Size (2015-2020)
7.2 Site-Specific Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Site-Specific Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Site-Specific Drug Delivery Market Size by Application (2015-2020)
8 China
8.1 China Site-Specific Drug Delivery Market Size (2015-2020)
8.2 Site-Specific Drug Delivery Key Players in China (2019-2020)
8.3 China Site-Specific Drug Delivery Market Size by Type (2015-2020)
8.4 China Site-Specific Drug Delivery Market Size by Application (2015-2020)
9 Japan
9.1 Japan Site-Specific Drug Delivery Market Size (2015-2020)
9.2 Site-Specific Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Site-Specific Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Site-Specific Drug Delivery Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Site-Specific Drug Delivery Market Size (2015-2020)
10.2 Site-Specific Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Site-Specific Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Site-Specific Drug Delivery Market Size by Application (2015-2020)
11 India
11.1 India Site-Specific Drug Delivery Market Size (2015-2020)
11.2 Site-Specific Drug Delivery Key Players in India (2019-2020)
11.3 India Site-Specific Drug Delivery Market Size by Type (2015-2020)
11.4 India Site-Specific Drug Delivery Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Site-Specific Drug Delivery Market Size (2015-2020)
12.2 Site-Specific Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Site-Specific Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Site-Specific Drug Delivery Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Site-Specific Drug Delivery Introduction
13.1.4 Johnson & Johnson Revenue in Site-Specific Drug Delivery Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Details
13.2.2 Gilead Sciences Business Overview
13.2.3 Gilead Sciences Site-Specific Drug Delivery Introduction
13.2.4 Gilead Sciences Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.2.5 Gilead Sciences Recent Development
13.3 Pacira
13.3.1 Pacira Company Details
13.3.2 Pacira Business Overview
13.3.3 Pacira Site-Specific Drug Delivery Introduction
13.3.4 Pacira Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.3.5 Pacira Recent Development
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Details
13.4.2 Sun Pharmaceutical Business Overview
13.4.3 Sun Pharmaceutical Site-Specific Drug Delivery Introduction
13.4.4 Sun Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.4.5 Sun Pharmaceutical Recent Development
13.5 Luye Pharma
13.5.1 Luye Pharma Company Details
13.5.2 Luye Pharma Business Overview
13.5.3 Luye Pharma Site-Specific Drug Delivery Introduction
13.5.4 Luye Pharma Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.5.5 Luye Pharma Recent Development
13.6 Sigma-Tau Group
13.6.1 Sigma-Tau Group Company Details
13.6.2 Sigma-Tau Group Business Overview
13.6.3 Sigma-Tau Group Site-Specific Drug Delivery Introduction
13.6.4 Sigma-Tau Group Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.6.5 Sigma-Tau Group Recent Development
13.7 Fudan-Zhangjiang
13.7.1 Fudan-Zhangjiang Company Details
13.7.2 Fudan-Zhangjiang Business Overview
13.7.3 Fudan-Zhangjiang Site-Specific Drug Delivery Introduction
13.7.4 Fudan-Zhangjiang Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.7.5 Fudan-Zhangjiang Recent Development
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Details
13.8.2 Teva Pharmaceutical Business Overview
13.8.3 Teva Pharmaceutical Site-Specific Drug Delivery Introduction
13.8.4 Teva Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.8.5 Teva Pharmaceutical Recent Development
13.9 CSPC
13.9.1 CSPC Company Details
13.9.2 CSPC Business Overview
13.9.3 CSPC Site-Specific Drug Delivery Introduction
13.9.4 CSPC Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.9.5 CSPC Recent Development
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview
13.10.3 Novartis Site-Specific Drug Delivery Introduction
13.10.4 Novartis Revenue in Site-Specific Drug Delivery Business (2015-2020)
13.10.5 Novartis Recent Development
13.11 Kingond Pharm
10.11.1 Kingond Pharm Company Details
10.11.2 Kingond Pharm Business Overview
10.11.3 Kingond Pharm Site-Specific Drug Delivery Introduction
10.11.4 Kingond Pharm Revenue in Site-Specific Drug Delivery Business (2015-2020)
10.11.5 Kingond Pharm Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Site-Specific Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Site-Specific Drug Delivery Revenue
Table 3. Ranking of Global Top Site-Specific Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Site-Specific Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposomal Doxorubicin
Table 6. Key Players of Liposomal Amphoteracin B
Table 7. Key Players of Liposomal Paclitaxel
Table 8. Key Players of Other
Table 9. Global Site-Specific Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Site-Specific Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Site-Specific Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Site-Specific Drug Delivery Market Share by Regions (2015-2020)
Table 13. Global Site-Specific Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Site-Specific Drug Delivery Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Site-Specific Drug Delivery Market Growth Strategy
Table 19. Main Points Interviewed from Key Site-Specific Drug Delivery Players
Table 20. Global Site-Specific Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 21. Global Site-Specific Drug Delivery Market Share by Players (2015-2020)
Table 22. Global Top Site-Specific Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Site-Specific Drug Delivery as of 2019)
Table 23. Global Site-Specific Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Site-Specific Drug Delivery Product Solution and Service
Table 26. Date of Enter into Site-Specific Drug Delivery Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 29. Global Site-Specific Drug Delivery Market Size Share by Type (2015-2020)
Table 30. Global Site-Specific Drug Delivery Revenue Market Share by Type (2021-2026)
Table 31. Global Site-Specific Drug Delivery Market Size Share by Application (2015-2020)
Table 32. Global Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 33. Global Site-Specific Drug Delivery Market Size Share by Application (2021-2026)
Table 34. North America Key Players Site-Specific Drug Delivery Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Site-Specific Drug Delivery Market Share (2019-2020)
Table 36. North America Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 37. North America Site-Specific Drug Delivery Market Share by Type (2015-2020)
Table 38. North America Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 39. North America Site-Specific Drug Delivery Market Share by Application (2015-2020)
Table 40. Europe Key Players Site-Specific Drug Delivery Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Site-Specific Drug Delivery Market Share (2019-2020)
Table 42. Europe Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Site-Specific Drug Delivery Market Share by Type (2015-2020)
Table 44. Europe Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Site-Specific Drug Delivery Market Share by Application (2015-2020)
Table 46. China Key Players Site-Specific Drug Delivery Revenue (2019-2020) (Million US$)
Table 47. China Key Players Site-Specific Drug Delivery Market Share (2019-2020)
Table 48. China Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 49. China Site-Specific Drug Delivery Market Share by Type (2015-2020)
Table 50. China Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 51. China Site-Specific Drug Delivery Market Share by Application (2015-2020)
Table 52. Japan Key Players Site-Specific Drug Delivery Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Site-Specific Drug Delivery Market Share (2019-2020)
Table 54. Japan Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Site-Specific Drug Delivery Market Share by Type (2015-2020)
Table 56. Japan Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Site-Specific Drug Delivery Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Site-Specific Drug Delivery Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Site-Specific Drug Delivery Market Share (2019-2020)
Table 60. Southeast Asia Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Site-Specific Drug Delivery Market Share by Type (2015-2020)
Table 62. Southeast Asia Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Site-Specific Drug Delivery Market Share by Application (2015-2020)
Table 64. India Key Players Site-Specific Drug Delivery Revenue (2019-2020) (Million US$)
Table 65. India Key Players Site-Specific Drug Delivery Market Share (2019-2020)
Table 66. India Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 67. India Site-Specific Drug Delivery Market Share by Type (2015-2020)
Table 68. India Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 69. India Site-Specific Drug Delivery Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Site-Specific Drug Delivery Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Site-Specific Drug Delivery Market Share (2019-2020)
Table 72. Central & South America Site-Specific Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Site-Specific Drug Delivery Market Share by Type (2015-2020)
Table 74. Central & South America Site-Specific Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Site-Specific Drug Delivery Market Share by Application (2015-2020)
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Product
Table 79. Johnson & Johnson Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 80. Johnson & Johnson Recent Development
Table 81. Gilead Sciences Company Details
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Product
Table 84. Gilead Sciences Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 85. Gilead Sciences Recent Development
Table 86. Pacira Company Details
Table 87. Pacira Business Overview
Table 88. Pacira Product
Table 89. Pacira Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 90. Pacira Recent Development
Table 91. Sun Pharmaceutical Company Details
Table 92. Sun Pharmaceutical Business Overview
Table 93. Sun Pharmaceutical Product
Table 94. Sun Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 95. Sun Pharmaceutical Recent Development
Table 96. Luye Pharma Company Details
Table 97. Luye Pharma Business Overview
Table 98. Luye Pharma Product
Table 99. Luye Pharma Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 100. Luye Pharma Recent Development
Table 101. Sigma-Tau Group Company Details
Table 102. Sigma-Tau Group Business Overview
Table 103. Sigma-Tau Group Product
Table 104. Sigma-Tau Group Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 105. Sigma-Tau Group Recent Development
Table 106. Fudan-Zhangjiang Company Details
Table 107. Fudan-Zhangjiang Business Overview
Table 108. Fudan-Zhangjiang Product
Table 109. Fudan-Zhangjiang Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 110. Fudan-Zhangjiang Recent Development
Table 111. Teva Pharmaceutical Business Overview
Table 112. Teva Pharmaceutical Product
Table 113. Teva Pharmaceutical Company Details
Table 114. Teva Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 115. Teva Pharmaceutical Recent Development
Table 116. CSPC Company Details
Table 117. CSPC Business Overview
Table 118. CSPC Product
Table 119. CSPC Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 120. CSPC Recent Development
Table 121. Novartis Company Details
Table 122. Novartis Business Overview
Table 123. Novartis Product
Table 124. Novartis Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 125. Novartis Recent Development
Table 126. Kingond Pharm Company Details
Table 127. Kingond Pharm Business Overview
Table 128. Kingond Pharm Product
Table 129. Kingond Pharm Revenue in Site-Specific Drug Delivery Business (2015-2020) (Million US$)
Table 130. Kingond Pharm Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Site-Specific Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Liposomal Doxorubicin Features
Figure 3. Liposomal Amphoteracin B Features
Figure 4. Liposomal Paclitaxel Features
Figure 5. Other Features
Figure 6. Global Site-Specific Drug Delivery Market Share by Application: 2020 VS 2026
Figure 7. Fungal Infection Therapy Case Studies
Figure 8. Cancer & Tumor Therapy Case Studies
Figure 9. Other Case Studies
Figure 10. Site-Specific Drug Delivery Report Years Considered
Figure 11. Global Site-Specific Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Site-Specific Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 13. Global Site-Specific Drug Delivery Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Site-Specific Drug Delivery Market Share by Players in 2019
Figure 16. Global Top Site-Specific Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Site-Specific Drug Delivery as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Site-Specific Drug Delivery Revenue in 2019
Figure 18. North America Site-Specific Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Site-Specific Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Site-Specific Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Site-Specific Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Site-Specific Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Site-Specific Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Site-Specific Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetes Therapy and Drug Delivery Scope and …- 次世代糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
- ドラッグデリバリーにおけるナノテクノロジーの世界市場（～2026年） Drug Delivery Systems (DDS) refers to the different Delivery forms of various therapeutic drugs adopted by people in the process of disease prevention and treatment, which were called dosage forms in pharmacy before the 1960s. Rising demand from Asia-Pacific region a major driver for the growth of t…
- 肺ドラッグデリバリーシステム（PDDS）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Drug Delivery System (PDDS) Market The global Pulmonary Drug Delivery System (PDDS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Drug Delivery System (PDDS) S…
- 鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…